Topics

STAT Plus: Fibrogen discloses new data that eases heart-safety concerns about experimental anemia pill

15:32 EST 8 Nov 2019 | STAT

Fibrogen presented new clinical trial data on Friday that alleviates concerns about the heart safety of its experimental anemia pill.

Original Article: STAT Plus: Fibrogen discloses new data that eases heart-safety concerns about experimental anemia pill

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: Fibrogen discloses new data that eases heart-safety concerns about experimental anemia pill"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...